SCHEMBL8528903

SCHEMBL8528903

COC(=O)CCC(=O)OC(Cl)(Cl)CCl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.54
LMNA P02545 3/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.38
CA12 O43570 1/20 0.36
CA14 Q9ULX7 1/20 0.36
RECQL P46063 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
TET2 Q6N021 1/20 0.33
ESRRB O95718 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439608 0.89 TSHR (0.33) TSHR
SCHEMBL733968 0.81 ALDH1A1 (0.46) TSHRLMNAALDH1A1
SCHEMBL9095803 0.78 ALDH1A1 (0.41) TSHRLMNAKDM4EALDH1A1KMT2A
SCHEMBL8527978 0.76 ALDH1A1 (0.33) ALDH1A1KMT2ARECQL
SCHEMBL7735640 0.76 TSHR (0.31) TSHRL3MBTL1
SCHEMBL2171693 0.75 TSHR (0.32) TSHR
SCHEMBL8945727 0.75 DGKA (0.50) TSHRLMNAKDM4EALDH1A1KMT2A
SCHEMBL8945612 0.75 DGKA (0.50) TSHRLMNAKDM4EALDH1A1KMT2A
Dimethyl Succinate SCHEMBL28054469 0.74 TSHR (1.00) TSHRLMNAKDM4EALDH1A1KMT2A
Dimethyl Succinate SCHEMBL10213 0.74 TSHR (1.00) TSHRLMNAKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821236-A Tumor treatment with arabinofuranosyl purine derivatives GLAXO WELLCOME INC. (US) 1998-10-13 US disclosed
US-5747472-A ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. (US) 1998-05-05 US disclosed
EP-0539479-B1 HETEROCYCLIC COMPOUNDS WELLCOME FOUND (GB) 1997-04-16 EP disclosed
US-5492897-A ANTITUMOR AGENTS, AUTOIMMUNE DISEASES BURROUGHS WELLCOME CO. (141) (US) 1996-02-20 US disclosed
EP-0539479-A1 HETEROCYCLIC COMPOUNDS. WELLCOME FOUND (GB) 1993-05-05 EP disclosed
WO-1992001456-A1 HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1992-02-06 WO disclosed